---
figid: PMC3913061__nihms549305f1
figlink: /pmc/articles/PMC3913061/figure/F1/
number: Figure 1
caption: The BRAFV600E oncoprotein elicits dramatically an increased kinase activity
  and activates phospho-ERK1/2. This oncoprotein is constitutively active and does
  not require RAS signaling. The BRAFV600E -activated phospho-ERK1/2 pathway is able
  to transform normal thyroid cells (NT) to thyroid cancer cells (TC). It up-regulates
  some extracellular matrix (ECM) non-cellular components (i.e. Thrombospondin-1 (TSP-1),
  Fibronectin) and cellular trans-membrane receptors (e.g. integrins), which together
  may increase the levels of phospho-ERK1/2 through a positive feedback driven by
  TSP-1. These pathological processes trigger ECM remodeling and determines tumor
  cell invasion into the lymphatic (LV) and/or blood vessels (BV) through basement
  membrane causing thyroid cancer progression.
pmcid: PMC3913061
papertitle: 'BRAFV600E and microenvironment in thyroid cancer: a functional link to
  drive cancer progression.'
reftext: Carmelo Nucera, et al. Cancer Res. ;71(7):2417-2422.
pmc_ranked_result_index: '11249'
pathway_score: 0.8847178
filename: nihms549305f1.jpg
figtitle: 'BRAFV600E and microenvironment in thyroid cancer: a functional link to
  drive cancer progression'
year: ''
organisms: Homo sapiens
ndex: b7bd2749-df17-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3913061__nihms549305f1.html
  '@type': Dataset
  description: The BRAFV600E oncoprotein elicits dramatically an increased kinase
    activity and activates phospho-ERK1/2. This oncoprotein is constitutively active
    and does not require RAS signaling. The BRAFV600E -activated phospho-ERK1/2 pathway
    is able to transform normal thyroid cells (NT) to thyroid cancer cells (TC). It
    up-regulates some extracellular matrix (ECM) non-cellular components (i.e. Thrombospondin-1
    (TSP-1), Fibronectin) and cellular trans-membrane receptors (e.g. integrins),
    which together may increase the levels of phospho-ERK1/2 through a positive feedback
    driven by TSP-1. These pathological processes trigger ECM remodeling and determines
    tumor cell invasion into the lymphatic (LV) and/or blood vessels (BV) through
    basement membrane causing thyroid cancer progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK13
  - MAPK12
  - KRAS
  - NRAS
  - MAPK8
  - MAPK9
  - MAPK3
  - MAPK14
  - MAP2K3
  - MAPK10
  - THBS1
  - MAP2K4
  - MAP2K7
  - MAPK1
  - MAP2K2
  - MAPK11
  - HRAS
  - MAP2K6
  - MAP2K1
  - MAP2K5
  - Tyrosine
genes:
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: TSP-1
  symbol: TSP-1
  source: hgnc_alias_symbol
  hgnc_symbol: THBS1
  entrez: '7057'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: (MAPKK)
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K5
  entrez: '5607'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases: []
---
